Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

BUY
$0.36 - $0.49 $3,898 - $5,305
10,828 New
10,828 $4,000
Q1 2022

May 10, 2022

SELL
$0.7 - $1.51 $3,572 - $7,707
-5,104 Reduced 32.04%
10,828 $8,000
Q4 2021

Feb 07, 2022

BUY
$1.16 - $2.23 $18,481 - $35,528
15,932 New
15,932 $21,000

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Lane Generational LLC Portfolio

Follow Lane Generational LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lane Generational LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lane Generational LLC with notifications on news.